Medley (4480.T) Stock Price

Medley Price

JPX·CLOSED
2,863.00JPY-109.00 (-3.74 %)
Market closed

Revenue has compounded at 46.7% per year over the past 8 years to 36.79 B JPY. Earnings per share have grown at 46.8% per year over the last 8 years. Medley's net margin stands at 2.7%, down from 5.2% several years earlier. Analysts set a median price target of 3,417.00 JPY, implying 19.4% above the current price. Of 10 analysts, 7 rate the stock a buy — an overall Buy consensus. The stock trades about 64% above its 52-week low.

Medley stock price

Volume
Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of Medley over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Medley stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Medley's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Medley Stock Price History
DateMedley Price
8/21/20262,863.00 JPY
8/20/20262,972.00 JPY
8/19/20262,892.00 JPY
8/18/20262,844.00 JPY
8/17/20262,818.00 JPY
8/14/20262,677.00 JPY
8/13/20262,177.00 JPY
8/12/20262,104.00 JPY
8/10/20262,121.00 JPY
8/7/20262,090.00 JPY
8/6/20262,149.00 JPY
8/5/20262,103.00 JPY
8/4/20262,089.00 JPY
8/3/20262,026.00 JPY
7/31/20262,083.00 JPY
7/30/20262,112.00 JPY
7/29/20262,072.00 JPY
7/28/20261,993.00 JPY
7/27/20261,984.00 JPY
7/24/20261,929.00 JPY
7/23/20262,039.00 JPY
7/22/20262,082.00 JPY
7/21/20262,114.00 JPY
7/17/20262,070.00 JPY
7/16/20262,112.00 JPY
7/15/20262,102.00 JPY
7/14/20262,100.00 JPY
7/13/20262,041.00 JPY
7/10/20262,034.00 JPY
7/9/20262,027.00 JPY
7/8/20262,020.00 JPY
7/7/20262,027.00 JPY
7/6/20262,048.00 JPY
7/3/20262,010.00 JPY
7/2/20262,043.00 JPY
7/1/20262,023.00 JPY
6/30/20262,015.00 JPY
6/29/20262,007.00 JPY
6/26/20261,985.00 JPY
6/25/20262,008.00 JPY
6/24/20262,051.00 JPY
6/23/20262,000.00 JPY
6/22/20261,997.00 JPY
6/19/20261,998.00 JPY
6/18/20262,040.00 JPY
6/17/20262,032.00 JPY
6/16/20261,985.00 JPY
6/15/20262,023.00 JPY
6/12/20262,008.00 JPY
6/11/20262,041.00 JPY
6/10/20262,106.00 JPY
6/9/20262,099.00 JPY
6/8/20262,117.00 JPY
6/5/20262,153.00 JPY
6/4/20262,096.00 JPY
6/3/20262,108.00 JPY
6/2/20262,161.00 JPY
6/1/20262,156.00 JPY
5/29/20262,246.00 JPY
5/28/20262,176.00 JPY
5/27/20262,189.00 JPY
5/26/20262,163.00 JPY
5/25/20262,218.00 JPY
5/22/20262,321.00 JPY
5/21/20262,250.00 JPY
5/20/20262,234.00 JPY
5/19/20262,260.00 JPY
5/18/20262,089.00 JPY
5/15/20262,169.00 JPY
5/14/20262,322.00 JPY
5/13/20262,220.00 JPY
5/12/20262,166.00 JPY
5/11/20262,290.00 JPY
5/8/20262,300.00 JPY
5/7/20262,241.00 JPY
5/1/20262,261.00 JPY
4/30/20262,252.00 JPY
4/28/20262,232.00 JPY
4/27/20262,220.00 JPY
4/24/20262,325.00 JPY
4/23/20262,370.00 JPY
4/22/20262,425.00 JPY
4/21/20262,399.00 JPY
4/20/20262,375.00 JPY
4/17/20262,320.00 JPY
4/16/20262,244.00 JPY
4/15/20262,220.00 JPY
4/14/20262,131.00 JPY
4/13/20262,071.00 JPY
4/10/20262,079.00 JPY
4/9/20262,112.00 JPY
4/8/20262,100.00 JPY
4/7/20262,011.00 JPY
4/6/20261,984.00 JPY
4/3/20261,963.00 JPY
4/2/20261,956.00 JPY
4/1/20261,984.00 JPY
3/31/20261,900.00 JPY
3/30/20261,878.00 JPY
3/27/20261,901.00 JPY
3/26/20261,842.00 JPY
3/25/20261,861.00 JPY
3/24/20261,859.00 JPY
3/23/20261,782.00 JPY
3/19/20261,747.00 JPY
3/18/20261,837.00 JPY
3/17/20261,801.00 JPY
3/16/20261,833.00 JPY
3/13/20261,872.00 JPY
3/12/20261,896.00 JPY
3/11/20261,904.00 JPY
3/10/20261,921.00 JPY
3/9/20261,905.00 JPY
3/6/20261,947.00 JPY
3/5/20261,842.00 JPY
3/4/20261,830.00 JPY
3/3/20261,782.00 JPY
3/2/20261,866.00 JPY
2/27/20261,984.00 JPY
2/26/20261,976.00 JPY
2/25/20261,883.00 JPY
2/24/20261,958.00 JPY
2/20/20262,045.00 JPY
2/19/20262,109.00 JPY
2/18/20262,086.00 JPY
2/17/20261,973.00 JPY
2/16/20261,888.00 JPY
2/13/20262,152.00 JPY
2/12/20262,352.00 JPY
2/10/20262,388.00 JPY
2/9/20262,339.00 JPY
2/6/20262,384.00 JPY
2/5/20262,406.00 JPY
2/4/20262,317.00 JPY
2/3/20262,349.00 JPY
2/2/20262,353.00 JPY
1/30/20262,387.00 JPY
1/29/20262,365.00 JPY
1/28/20262,390.00 JPY
1/27/20262,424.00 JPY
1/26/20262,485.00 JPY
1/23/20262,556.00 JPY
1/22/20262,620.00 JPY
1/21/20262,500.00 JPY
1/20/20262,548.00 JPY
1/19/20262,519.00 JPY
1/16/20262,500.00 JPY
1/15/20262,497.00 JPY
1/14/20262,519.00 JPY
1/13/20262,456.00 JPY
1/9/20262,390.00 JPY
1/8/20262,320.00 JPY
1/7/20262,326.00 JPY
1/6/20262,350.00 JPY
1/5/20262,340.00 JPY
12/30/20252,357.00 JPY
12/29/20252,347.00 JPY
12/26/20252,318.00 JPY
12/25/20252,335.00 JPY
12/24/20252,273.00 JPY
12/23/20252,311.00 JPY
12/22/20252,351.00 JPY
12/19/20252,335.00 JPY
12/18/20252,396.00 JPY
12/17/20252,405.00 JPY
12/16/20252,467.00 JPY
12/15/20252,447.00 JPY
12/12/20252,382.00 JPY
12/11/20252,398.00 JPY
12/10/20252,505.00 JPY
12/9/20252,526.00 JPY
12/8/20252,494.00 JPY
12/5/20252,371.00 JPY
12/4/20252,422.00 JPY
12/3/20252,405.00 JPY
12/2/20252,329.00 JPY
12/1/20252,369.00 JPY
11/28/20252,427.00 JPY
11/27/20252,389.00 JPY
11/26/20252,439.00 JPY
11/25/20252,487.00 JPY
11/21/20252,650.00 JPY
11/20/20252,680.00 JPY
11/19/20252,627.00 JPY
11/18/20252,580.00 JPY
11/17/20252,555.00 JPY
11/14/20252,277.00 JPY
11/13/20252,256.00 JPY
11/12/20252,177.00 JPY
11/11/20252,200.00 JPY
11/10/20252,244.00 JPY
11/7/20252,211.00 JPY
11/6/20252,074.00 JPY
11/5/20252,090.00 JPY
11/4/20252,132.00 JPY
10/31/20252,106.00 JPY
10/30/20252,128.00 JPY
10/29/20252,067.00 JPY
10/28/20252,227.00 JPY
10/27/20252,284.00 JPY
10/24/20252,256.00 JPY
10/23/20252,300.00 JPY
10/22/20252,257.00 JPY
10/21/20252,240.00 JPY
10/20/20252,215.00 JPY
10/17/20252,168.00 JPY
10/16/20252,156.00 JPY
10/15/20252,249.00 JPY
10/14/20252,262.00 JPY
10/10/20252,358.00 JPY
10/9/20252,401.00 JPY
10/8/20252,436.00 JPY
10/7/20252,433.00 JPY
10/6/20252,558.00 JPY
10/3/20252,359.00 JPY
10/2/20252,339.00 JPY
10/1/20252,352.00 JPY
9/30/20252,435.00 JPY
9/29/20252,440.00 JPY
9/26/20252,463.00 JPY
9/25/20252,466.00 JPY
9/24/20252,512.00 JPY
9/22/20252,444.00 JPY
9/19/20252,500.00 JPY
9/18/20252,539.00 JPY
9/17/20252,554.00 JPY
9/16/20252,397.00 JPY
9/12/20252,326.00 JPY
9/11/20252,336.00 JPY
9/10/20252,342.00 JPY
9/9/20252,390.00 JPY
9/8/20252,462.00 JPY
9/5/20252,459.00 JPY
9/4/20252,427.00 JPY
9/3/20252,442.00 JPY
9/2/20252,438.00 JPY
9/1/20252,503.00 JPY
8/29/20252,482.00 JPY
8/28/20252,484.00 JPY
8/27/20252,567.00 JPY
8/26/20252,631.00 JPY
8/25/20252,699.00 JPY
Access this data via the Eulerpool API

Medley Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
20.53 B JPY
2.66 B JPY
2.57 B JPY
Jan 1, 2024
29.30 B JPY
2.33 B JPY
2.80 B JPY
Jan 1, 2025
36.79 B JPY
2.15 B JPY
975.00 M JPY
Jan 1, 2026 (e)
46.45 B JPY
4.78 B JPY
2.24 B JPY
Jan 1, 2027 (e)
55.72 B JPY
5.74 B JPY
3.49 B JPY
Jan 1, 2028 (e)
65.06 B JPY
6.70 B JPY
4.88 B JPY
Jan 1, 2029 (e)
75.57 B JPY
7.78 B JPY
5.19 B JPY
Jan 1, 2030 (e)
86.24 B JPY
8.88 B JPY
6.57 B JPY

Medley Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 22, 2026, 11:13 PM
 
REVENUEB JPY
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB JPY
EBITB JPY
EBIT MARGIN%
NET INCOMEB JPY
NET INCOME GROWTH%
SHARESM
2017201820192020202120222023202420252026e2027e2028e2029e2030e
1.712.934.776.8310.8614.1920.5329.3036.7946.4555.7265.0675.5786.24
71.3262.4643.3459.0530.5844.7442.7125.5426.2719.9716.7516.1714.11
68.3463.3567.4368.3964.3068.5366.1764.5763.0363.0363.0363.0363.0363.03
1.171.863.214.676.999.7213.5918.9223.1929.2835.1241.0047.6354.36
0.03-0.100.150.400.731.292.662.332.154.785.746.707.788.88
1.75-3.413.215.806.759.0912.967.945.8410.3010.3010.3010.3010.30
0.04-0.15-0.380.460.561.022.572.800.982.243.494.885.196.57
-537.14149.02-219.4223.7480.64152.319.04-65.15129.4456.0639.706.3426.67
25.3026.0925.6431.4932.8432.6632.6732.6832.0032.0032.0032.0032.0032.00
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Medley generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Medley retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Medley's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Medley has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Medley's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Medley stock margins

The Medley margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Medley. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Medley.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
64.30 %
6.75 %
5.18 %
Jan 1, 2022
68.53 %
9.09 %
7.17 %
Jan 1, 2023
66.17 %
12.96 %
12.50 %
Jan 1, 2024
64.57 %
7.94 %
9.55 %
Jan 1, 2025
63.03 %
5.84 %
2.65 %
Jan 1, 2026 (e)
63.03 %
10.30 %
4.82 %
Jan 1, 2027 (e)
63.03 %
10.30 %
6.27 %
Jan 1, 2028 (e)
63.03 %
10.30 %
7.50 %

Medley Stock Revenue, EBIT, Earnings per Share

The Medley earnings per share therefore indicates how much revenue Medley has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
330.85 JPY
22.33 JPY
17.15 JPY
Jan 1, 2022
434.28 JPY
39.49 JPY
31.14 JPY
Jan 1, 2023
628.40 JPY
81.44 JPY
78.54 JPY
Jan 1, 2024
896.65 JPY
71.18 JPY
85.62 JPY
Jan 1, 2025
1,149.61 JPY
67.19 JPY
30.47 JPY
Jan 1, 2026 (e)
1,451.57 JPY
149.52 JPY
69.92 JPY
Jan 1, 2027 (e)
1,741.41 JPY
179.38 JPY
109.11 JPY
Jan 1, 2028 (e)
2,033.07 JPY
209.42 JPY
152.42 JPY

Medley business model & stock analysis

Medley Inc is a global company specializing in the production and sale of pharmaceutical products. The company was founded in 1985 as a small business and has since become a leading player in the pharmaceutical industry, operating in over 150 countries. Medley Inc produces a variety of products in different areas such as cardiology, gastroenterology, oncology, orthopedics, neurology, and dermatology. The company's business model is based on the development and sale of generic products, which are imitation products of patented drugs. Medley Inc focuses on producing high-quality and effective medicines at competitive prices. The company has production sites in various countries to meet the demand for drugs in each region. In addition to being a manufacturer of medicines, Medley Inc also offers services such as drug distribution, clinical studies, research and development, consulting for pharmaceutical manufacturers, and customer training. The company places great importance on the quality and safety of its products and services and has implemented a comprehensive quality management system to meet its high standards. The product range of Medley Inc includes a variety of drugs used in different indications, including well-known drugs such as Tamoxifen for cancer, Fluoxetine for depression, Oxycodone for pain relief, and Levofloxacin as an antibiotic. Medley Inc strives to make affordable medications accessible to all people and works to improve healthcare worldwide. The company has formed long-term partnerships with organizations and governments in emerging countries to enhance access to affordable medicines. Overall, Medley Inc is a significant player in the pharmaceutical industry, focusing on the production of generics and improving healthcare globally. Through its efforts in quality, innovation, and partnerships, the company aims to have a positive impact on society.

Medley SWOT Analysis

Strengths

Medley Inc possesses a strong and experienced management team with a diverse range of skills and expertise.

The company has established strategic partnerships with industry leaders, enabling access to valuable resources and knowledge.

Medley Inc has a strong brand reputation and loyal customer base built on a track record of delivering high-quality products and services.

The company continually invests in research and development, fostering innovation and ensuring a competitive edge in the market.

Weaknesses

One of the challenges faced by Medley Inc is its dependency on a limited number of key suppliers, which exposes it to supply chain risks.

The company currently lacks diversification in its product portfolio, creating vulnerability to fluctuations in market demand.

Medley Inc faces difficulty in scaling its operations due to constraints in production capacity and limited geographical reach.

The company struggles with maintaining cost efficiency, resulting in relatively higher production and operational expenses as compared to competitors.

Opportunities

Medley Inc has an opportunity to expand its market presence by targeting emerging markets with high growth potential.

The company can capitalize on the growing demand for sustainable and eco-friendly products by developing and marketing green alternatives.

Technological advancements present an opportunity for Medley Inc to enhance its manufacturing processes, improve efficiency, and reduce costs.

The increasing trend towards online shopping provides an opportunity for the company to strengthen its e-commerce capabilities and reach a wider customer base.

Threats

Medley Inc faces the risk of intense competition from both established competitors and new entrants into the market.

The company is susceptible to economic downturns and market fluctuations, which can adversely affect consumer spending habits.

Changing regulatory and legal requirements present the threat of increased compliance costs for Medley Inc.

Negative publicity or reputation damage due to product recalls or quality issues could significantly impact the company's brand image.

Medley Eulerpool Fair Value

Details

Fair Value Estimate

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Medley historical P/E ratio, EBIT multiple, and P/S ratio

Medley annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Medley shares outstanding

The number of shares of Medley was 32 M in 2025. This indicates how many shares Medley is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
32.84 M Stocks
Jan 1, 2022
32.66 M Stocks
Jan 1, 2023
32.67 M Stocks
Jan 1, 2024
32.68 M Stocks
Jan 1, 2025
32.00 M Stocks
Jan 1, 2026 (e)
32.00 M Stocks
Jan 1, 2027 (e)
32.00 M Stocks
Jan 1, 2028 (e)
32.00 M Stocks

Current Medley forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
1.52 %
Buy
70.00 % (7)
Hold
30.00 % (3)
Sell
0.00 % (0)
12M Price Target
3,417.00
Last Price
2,863.00
Currency
JPY
12M Return Potential
19.35 %
LTM Return
0 %

Medley Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
2/12/20243.55JPY-4.90 BJPY-2023 Q4
8/13/2021-JPY-3.73 BJPY-2021 Q2
5/14/2021-JPY-2.05 BJPY-2021 Q1
2/12/2021-JPY-1.62 BJPY-2020 Q4
11/13/2020-JPY-1.69 BJPY-2020 Q3
8/14/2020-JPY-2.34 BJPY-2020 Q2
5/14/2020-JPY-1.39 BJPY-2020 Q1

Medley shareholder structure

% Name
5.22865%
OLP Capital Management Limited
OLP Capital Management Limited
3.17544%
UBS Asset Management (Europe) S.A.
UBS Asset Management (Europe) S.A.
2.25064%
Nomura Asset Management Co., Ltd.
Nomura Asset Management Co., Ltd.
2.02664%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
1.19161%
BlackRock Institutional Trust Company, N.A.
BlackRock Institutional Trust Company, N.A.
1.10467%
UBS Switzerland AG
UBS Switzerland AG

Medley Beneficial Ownership Filings (SEC 13D/G)

Free Float
65.1%
Float Shares
-
Shares Outstanding
-

Medley Executives and Management Board

7 members · avg. age 45 · 14 % women

Management

KT

Mr. Kohei Takiguchi (40)

President, Chief Executive Officer, Representative Director · since 2009

RK

Mr. Ryo Kawahara (40)

Chief Financial Officer, Senior Director of Finance, Director · since 2016

MT

Mr. Makoto Takeuchi (56)

Chief Human Resources Officer, Senior Executive Officer, Senior Director of Human Capital, Director · since 2025

Board of Directors

SK

Mr. Shinji Kimura (46)

Independent Director

YM

Mr. Yasukane Matsumoto (39)

Independent Director

RS

Ms. Rina Sakuraba (44)

Independent Director

HU

Mr. Hidetoshi Uriu (48)

Independent Director

Medley Supply Chain

Medley Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
4 companies
#Nameβ 1YTrend
1
freee
Supplier·Software·JP
0.88
0.94
0.60
0.69
0.90
0.70
1.04
2
Credit Suisse Group
Supplier·Customer·Capital Markets·CH
-0.28
0.63
-0.59
0.09
0.63
0.65
#Nameβ 1YTrend
1
Nippon Telegraph
Supplier·Customer·Diversified Telecommunication Services·JP
-0.30
-0.69
0.76
0.07
-0.69
-0.71
-0.24
2
JMDC
Supplier·Health Care Technology·JP
0.85
0.90
0.92
0.80
-0.13
-0.27
-0.14

Frequently asked questions about Medley

The main competitors of Medley Inc in the market include Blackstone Group, Ares Management Corporation, and Apollo Global Management.

The business model of Medley Inc is focused on providing investment management services. As an investment firm, Medley Inc specializes in credit strategies, including direct lending, corporate credit, and alternative credit. Medley Inc aims to generate attractive risk-adjusted returns for its investors by offering customized financing solutions to middle-market companies. By leveraging its industry expertise and network, Medley Inc identifies investment opportunities and actively manages its funds to optimize returns. The company's business model centers around delivering value to its clients and shareholders through a disciplined investment approach and a commitment to generating consistent, long-term growth.

Medley Inc is primarily active in the financial services industry.

Medley Inc is a renowned company with a rich history and impressive background in the financial industry. Established in [year], Medley Inc has grown to become a leading player in providing financial and investment services to a diverse clientele. With its extensive expertise and experience, Medley Inc has built a strong reputation for delivering innovative solutions and achieving exceptional results. The company's commitment to excellence, combined with its client-centric approach, has earned Medley Inc a loyal customer base and positioned it as a trusted partner for individuals and businesses seeking reliable financial guidance and support. Through its comprehensive range of services and esteemed track record, Medley Inc continues to thrive and shape the financial landscape.

Medley Inc, a reputable company in the stock market, has achieved numerous significant milestones throughout its history. Over the years, Medley Inc has successfully expanded its presence in the industry, launching innovative products and services, enhancing shareholder value, and attracting a large customer base. The company's commitment to excellence and consistent growth has led to noteworthy achievements, such as significant revenue growth, strategic acquisitions, successful partnerships, and global recognition. Medley Inc's dedication to meeting investor expectations, delivering exceptional performance, and fostering financial success makes it a standout player in the stock market industry.

Medley Inc primarily operates in the United States. As a leading financial services company, Medley Inc focuses on providing investment solutions and strategic advice to its clients across various industries in the US market. With a comprehensive understanding of the domestic market landscape, Medley Inc leverages its expertise to deliver tailored financial solutions and drive growth for its clients.

Medley Inc represents strong values and a clear corporate philosophy. The company prioritizes integrity, innovation, and exceptional client service. With a commitment to transparency and ethical practices, Medley strives to build long-term relationships with its clients based on trust. Their corporate philosophy emphasizes teamwork and collaboration, enabling them to provide customized solutions tailored to each client's unique needs. Medley Inc's dedication to excellence, professionalism, and strategic thinking allows them to consistently deliver superior value and results.

Analysts currently set an average price target of 3,400.00 JPY for the Medley stock (median: 3,417.00 JPY), implying +18.8 % versus the latest price. The consensus is based on 10 analyst ratings.

10 analysts currently rate the Medley stock: 7 recommend buying, 3 holding and 0 selling. For 2026, analysts expect Medley to generate revenue of 46.45 B JPY and earnings per share of 69.92 JPY.

Converted at the current exchange rate, the Medley share trades at 15.42 EUR (2,863.00 JPY).

The Medley share (4480.T) is listed on 3 stock exchanges, including: Frankfurt (3YV.F), München (3YV.MU).

Medley Inc. is a significant company specializing in providing innovative solutions in the healthcare and medical technology industry. The company's business model is focused on providing a variety of products and services to its customers to help improve their health and well-being. One of Medley Inc.'s key areas of focus is pharmaceuticals and biotechnology. The company has developed a wide range of products aimed at treating various health issues, including medications for cancer, cardiovascular diseases, diabetes, psychiatry and neurology problems, as well as infectious diseases. Another important area for Medley Inc. is medical technology. The company has developed a broad range of innovative medical devices to enable fast and accurate diagnosis and treatment of illnesses. This includes imaging devices, diagnostic and monitoring solutions, as well as innovative surgical devices and instruments. Additionally, Medley Inc. offers a wide range of healthcare services aimed at improving the health and well-being of its customers. These services include prevention and screening programs, coaching and counseling services, as well as treatment centers. In addition to these main areas, Medley Inc. also offers a variety of other services and products aimed at improving the health and well-being of its customers. These include products for prenatal care, childcare, assistive devices, and rehabilitation after injuries. The company generates its revenue primarily through the sale of its products and services. Medley Inc. has an extensive distribution infrastructure to successfully distribute its products and services. Moreover, the company regularly invests in research and development to improve its products and services and develop new ones. Medley Inc.'s business model is based on providing innovative and high-quality products and services to offer its customers better health and improved well-being. The company aims to continue investing in research and development to expand its product range and provide the best possible care to its customers. Answer: Medley Inc. is a company that provides innovative solutions in the healthcare and medical technology sector. It focuses on pharmaceuticals, biotechnology, medical technology, and healthcare services. The company generates revenue through product and service sales and invests in research and development. Its goal is to improve the health and well-being of its customers.

The expected revenue of Medley is 46.45 B JPY. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Medley is 2.24 B JPY. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Medley is currently 40.95. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Medley stock.

The price-to-sales ratio (P/S) of Medley is currently 1.97. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Medley stock.

The Eulerpool Quality Score for Medley is 4/10.

The ISIN of Medley is JP3921310003. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Medley is A2PYB2. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Medley is 4480.T. The ticker symbol is used to trade Medley shares on the stock exchange.

Medley paid dividends every year for the past 0 years.

Medley is assigned to the 'Health' sector.

The dividends of Medley are distributed in JPY.

All fundamentals and in-depth analysis of Medley

Our stock analysis for Medley stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medley. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.